Neurones (NRO) Stock Statistics & Valuation Metrics

Neurones has a market cap or net worth of €1.11B. The enterprise value is ―.

Neurones has 24,278,715 shares outstanding. The number of shares has decreased by -2.65% in one year.

Neurones’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.51%.

The current PE Ratio of Neurones is 20.32. Neurones’s PEG ratio is 2.82.

In the last 12 months, Neurones had revenue of 810.40M and earned 52.50M in profits. Earnings per share was 2.17.

In the last 12 months, operating cash flow was 15.30M and capital expenditures -7.25M, giving a free cash flow of 8.05M billion.

Neurones pays an annual dividend of €1.2, resulting in a dividend yield of 2.6%

Neurones upcoming earnings date is Sep 10, 2025, TBA Not Confirmed.

Neurones as a current ratio of 2.33, with Debt / Equity ratio of 11.11%

In the past 12 months, Neurones has paid 24.90M in taxes.

Neurones EV to EBITDA ratio is 9.10, with an EV/FCF ratio of 0.00.

Neurones has €326.49M in cash and marketable securities with €42.02M in debt, giving a net cash position of -€284.47M billion.

Gross margin is 47.41%, with operating margin of 9.61%, and net profit margin of 6.48%.

The average price target for Neurones is ―, which is 11.43% higher than the current price. The consensus rating is ―